Peptidream and Novartis expand peptide discovery collaboration
April 30, 2024
Peptidream Inc. and Novartis Pharma AG have expanded their peptide-drug conjugate discovery collaboration announced in 2019, adding additional peptide radioligand therapies and other programs.